Publications by authors named "Claire Gross"

Hip problems are common in ballet dancers, and it is likely that dancers' perceived quality of life is impaired by their presence. There are no instruments to detect functional impairments related to hip injuries in young, athletic populations. The aim of this study was to evaluate the impact of hip related problems on the quality of life in professional ballet dancers.

View Article and Find Full Text PDF

Background: Higher body mass index (BMI) is associated with difficulty in obtaining imaging studies. While there is a small body of literature regarding the relationship between fluoroscopy time and BMI during injections for pain management, this has not been studied for intraarticular (IA) hip injections. Further, in academic training centers, trainee involvement may affect this relationship.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the link between Body Mass Index (BMI) and the time taken for fluoroscopy during sacroiliac joint injections used for pain relief.
  • Conducted across three pain treatment centers, the research analyzed data from 459 injections involving 350 patients, focusing on factors like median age, gender distribution, and BMI categories (normal, overweight, obese).
  • Results revealed no significant difference in fluoroscopy time among different BMI groups or procedural factors, suggesting that weight does not affect the duration of fluoroscopy during these injections.
View Article and Find Full Text PDF

Background: Airway epithelial cells are critical in host defense against bacteria including Mycoplasma pneumoniae (Mp) in chronic obstructive pulmonary disease (COPD) and asthma. beta2-agonists are mainstay of COPD and asthma therapy, but whether beta2-agonists directly affect airway epithelial host defense functions is unclear.

Methods: Epithelial cells from bronchial brushings of normal (n = 8), asthma (n = 8) and COPD (n = 8) subjects were grown in air-liquid interface cultures, and treated with cigarette smoke extract (CSE) and/or Th2 cytokine IL-13, followed by Mp infection and treatment with beta2-agonists albuterol and formoterol for up to seven days.

View Article and Find Full Text PDF